Substance P Activates Mast Cell Receptor MRGPRX2 Through Both G-Protein and Arrestin Pathways
Substance P acts as a balanced agonist at MRGPRX2, activating both G-protein and β-arrestin signaling, with a single tyrosine residue (Tyr279) essential for both pathways.
Quick Facts
What This Study Found
Substance P serves as a balanced agonist for MRGPRX2, activating both G-protein and β-arrestin pathways. Tyr279 in the NPxxY motif is essential for both signaling modes.
Key Numbers
2 pathways: G protein + beta-arrestin; Y279A blocks beta-arrestin and internalization; balanced agonism by SP
How They Did This
Cell-based assays measuring G-protein signaling, β-arrestin recruitment, MRGPRX2 internalization, and desensitization. Site-directed mutagenesis (Y279A). G-protein independence verified with G-protein inhibitors.
Why This Research Matters
MRGPRX2 is a key mediator of drug-induced pseudo-allergic reactions, neurogenic inflammation, and itch. Understanding how substance P activates this receptor could lead to better treatments for inflammatory skin conditions and drug reactions.
The Bigger Picture
MRGPRX2 has emerged as a major target for drug-induced pseudo-allergic reactions and neurogenic inflammation. Understanding that substance P causes both activation and self-limiting desensitization through balanced agonism provides insights for developing better anti-inflammatory strategies.
What This Study Doesn't Tell Us
Cell-based overexpression system may not fully reflect native receptor behavior. Focused on one agonist (substance P); other MRGPRX2 agonists may have different signaling profiles.
Questions This Raises
- ?Could biased MRGPRX2 agonists or antagonists be developed for specific therapeutic effects?
- ?Is the β-arrestin pathway protective or pathological in neurogenic inflammation?
- ?Do other neuropeptide MRGPRX2 agonists show similar balanced agonism?
Trust & Context
- Key Stat:
- Single residue controls dual signaling Tyr279 in MRGPRX2's NPxxY motif is essential for both G-protein and β-arrestin-mediated responses to substance P
- Evidence Grade:
- Rigorous in vitro mechanistic study with mutagenesis validation. Strong molecular pharmacology evidence.
- Study Age:
- Published in 2021, advancing understanding of MRGPRX2 pharmacology and substance P signaling.
- Original Title:
- Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.
- Published In:
- International journal of molecular sciences, 22(10) (2021)
- Authors:
- Chompunud Na Ayudhya, Chalatip, Amponnawarat, Aetas(2), Ali, Hydar(2)
- Database ID:
- RPEP-05321
Evidence Hierarchy
Frequently Asked Questions
What is MRGPRX2 and why does it matter?
MRGPRX2 is a receptor on mast cells that responds to various molecules including neuropeptides and certain drugs. When activated, it causes mast cells to release inflammatory chemicals. It's responsible for many drug-induced pseudo-allergic reactions and contributes to inflammatory skin conditions like eczema.
What does 'balanced agonist' mean?
It means substance P activates two different signaling pathways through MRGPRX2 equally. One pathway (G-protein) triggers mast cell activation, while the other (β-arrestin) leads to the receptor being pulled inside the cell, effectively shutting it down. This built-in on/off mechanism helps regulate the inflammatory response.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05321APA
Chompunud Na Ayudhya, Chalatip; Amponnawarat, Aetas; Ali, Hydar. (2021). Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.. International journal of molecular sciences, 22(10). https://doi.org/10.3390/ijms22105318
MLA
Chompunud Na Ayudhya, Chalatip, et al. "Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.." International journal of molecular sciences, 2021. https://doi.org/10.3390/ijms22105318
RethinkPeptides
RethinkPeptides Research Database. "Substance P Serves as a Balanced Agonist for MRGPRX2 and a S..." RPEP-05321. Retrieved from https://rethinkpeptides.com/research/chompunud-2021-substance-p-serves-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.